Showing results (31-40 of 108) with videos related to

Sort By:
Pageof 11
Cancer Medicine|July 23, 2025
Impact of Decitabine Conditioning on Allo-HSCT Outcomes in AML and Intermediate-to-High-Risk MDS Patients in RemissionShuling Yu, Wanchuan Zhuang, Shengfa Gao, et al.
Journal of Medicinal Chemistry|March 1, 2026
A ROS-Responsive Dimeric Prodrug Nanoassembly for Amplified Epigenetic Therapy of LymphomaTongyu Li, Wanchuan Zhuang, Shufang Fan, et al.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi = Zhonghua Yixue Yichuanxue Zazhi = Chinese Journal of Medical Genetics|October 11, 2019
[Analysis of mutations of 14 genes among 87 patients with myelodysplastic syndrome]Xuyan Zhou, He Jin, Qitian Mu, et al.
Leukemia Research|October 11, 2025
Low serum complement C3 levels are associated with adverse clinical outcomes in myelodysplastic syndromesDuobing Zou, Huanhuan Ying, Liang Yong, et al.
Folia Histochemica Et Cytobiologica|September 7, 2020
Upregulated miR-96-5p inhibits cell proliferation by targeting HBEGF in T-cell acute lymphoblastic leukemia cell lineKaihong Xu, Xiao Yan, Guifang Ouyang, et al.
Molecular Medicine Reports|November 9, 2017
Anticancer effect of quinacrine on diffuse large B‑cell lymphoma via inhibition of MSI2‑NUMB signaling pathwayShujun Yang, Lixia Sheng, Kaihong Xu, et al.
Medicine|April 6, 2018
Durable remission in a patient of mixed phenotype acute leukemia with Philadelphia chromosome-positive treated with nilotinib and lenalidomide: A case reportBinbin Lai, Qitian Mu, Huiling Zhu, et al.
International Immunopharmacology|December 22, 2025
Integrating global burden of disease analysis and single-cell omics identifies ANTXR2 as a potential diagnostic biomarker for AML in ChinaXinwen Zhang, Aiping Chen, Ying Chen, et al.
Human Cell|August 28, 2019
MicroRNA-532 exerts oncogenic functions in t(4;14) multiple myeloma by targeting CAMK2N1Kaihong Xu, Xuezhen Hu, Laifang Sun, et al.
Journal of Cancer Research and Therapeutics|March 27, 2018
Diffuse large B-cell lymphoma with concurrent hepatitis B virus infection in the MabThera era: Unique clinical features and worse outcomesXiao Yan, Miao Zhou, Zhongze Lou, et al.
Pageof 11